Resultados de la búsqueda 81-90 of 14165 for the understanding and treatment of gynecological conditions
PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers. Rochester, Minn. The purpose of this study is to determine the ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to find ...
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. The study is expected to last ...
ID predictors of surgical outcomes to identify/improve future treatments -Collect data, images, from patients undergoing surgical treatment of hip disorders ...
... conditions and the likelihood that they will ... A Study of Leukemia Inhibitory Factor Biomarker Monitoring Progression and Treatment Response of Locally-advanced ...
... the knowledge, beliefs, and attitudes of oncology ... Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since ...
Bimonthly eNewsletter focused on the trends in gastroenterology and hepatology-related procedures and disease management strategies at Mayo Clinic.
In this case, we seek to understand the mechanism of tumor spread and determine why people respond differently to specific cancer treatments. In general terms, ...
... disorders, for use in future studies of disease source, diagnosis, treatment, and prognosis. A Study of DNA/RNA Sequencing Results on the Clinical ...
Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since treatment start, whichever comes first.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?